BONANNI, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 15.474
NA - Nord America 14.823
AS - Asia 2.661
AF - Africa 113
SA - Sud America 31
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 4
Totale 33.134
Nazione #
US - Stati Uniti d'America 14.767
PL - Polonia 5.263
RU - Federazione Russa 4.343
IT - Italia 2.108
IE - Irlanda 1.314
SE - Svezia 1.064
SG - Singapore 809
HK - Hong Kong 524
CN - Cina 473
DE - Germania 299
IN - India 292
FI - Finlandia 272
UA - Ucraina 230
JO - Giordania 209
GB - Regno Unito 180
CH - Svizzera 165
TR - Turchia 163
VN - Vietnam 98
CI - Costa d'Avorio 78
ES - Italia 60
FR - Francia 56
CA - Canada 48
NL - Olanda 40
KR - Corea 27
AU - Australia 20
PH - Filippine 19
BE - Belgio 18
CZ - Repubblica Ceca 16
BR - Brasile 15
BG - Bulgaria 13
SC - Seychelles 11
ID - Indonesia 10
AR - Argentina 9
AT - Austria 7
RO - Romania 7
CO - Colombia 6
PT - Portogallo 6
BH - Bahrain 5
IR - Iran 5
MX - Messico 5
NZ - Nuova Zelanda 5
TH - Thailandia 5
EG - Egitto 4
EU - Europa 4
IL - Israele 4
JP - Giappone 4
MU - Mauritius 4
MW - Malawi 4
DZ - Algeria 3
FJ - Figi 3
MY - Malesia 3
NG - Nigeria 3
PK - Pakistan 3
ZA - Sudafrica 3
CM - Camerun 2
LV - Lettonia 2
NO - Norvegia 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AN - Antille olandesi 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
KZ - Kazakistan 1
LT - Lituania 1
MA - Marocco 1
MK - Macedonia 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 33.134
Città #
Warsaw 5.254
Santa Clara 2.779
Fairfield 1.607
Dublin 1.310
Chandler 1.096
Ashburn 789
Seattle 672
Woodbridge 668
Singapore 635
Cambridge 624
Houston 546
Wilmington 544
Princeton 392
Florence 357
Jacksonville 357
Lawrence 351
Altamura 319
Boston 290
Mumbai 256
Ann Arbor 255
Beijing 217
Hong Kong 208
Boardman 201
Moscow 198
Buffalo 193
Bern 155
Medford 137
San Diego 127
New York 115
Shanghai 114
Izmir 101
Dong Ket 85
Kent 85
Milan 79
Abidjan 78
Rome 76
Norwalk 64
Los Angeles 60
Barcelona 53
Dearborn 45
Bremen 41
Falls Church 41
Hillsboro 40
Toronto 38
Andover 31
London 30
Genoa 29
Phoenix 28
Yubileyny 27
Munich 25
Helsinki 23
Naples 20
Turin 20
Bari 18
Bologna 18
Salerno 18
Padova 17
Pisa 16
Seoul 16
Redwood City 15
Verona 15
Brussels 14
Catania 14
Pune 14
West Jordan 14
Ancona 13
Astoria 13
Guangzhou 13
Auburn Hills 12
Laurel 12
Palermo 12
Redmond 12
Bergamo 11
Frankfurt Am Main 11
Lappeenranta 11
Brno 10
Philadelphia 10
Prato 10
Washington 10
Baltimore 9
Parma 9
Rimini 9
Amsterdam 8
Napoli 8
Perugia 8
San Giuliano Terme 8
Sofia 8
Pescara 7
San Vito 7
Sassari 7
Campi Bisenzio 6
Caserta 6
Central 6
Manchester 6
Mendiolaza 6
Siena 6
Tappahannock 6
Torino 6
Trento 6
Vienna 6
Totale 22.382
Nome #
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 420
HPV vaccination for boys? A systematic review of economic studies 298
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 264
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 260
Beliefs and Opinions of Health Care Workers and Students Regarding Influenza and Influenza Vaccination in Tuscany, Central Italy 260
Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines 257
Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy 252
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 250
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 246
Vaccinating Italian infants with a new multicomponent vaccine (Bexsero®) against meningococcal B disease: A cost-effectiveness analysis 245
A summer school on vaccinology: Responding to identified gaps in pre-service immunisation training of future health care workers. 242
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015 240
Vaccination of boys or catch-up of girls above 11 years of age with the HPV-16/18 AS04-adjuvanted vaccine: Where is the greatest benefit for cervical cancer prevention in Italy? 237
Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy 236
Human papilloma virus vaccination: impact and recommendations across the world. 235
Coverage or Efficacy: Which Factor is the Most Influential for Reducing Varicella with Routine Childhood Vaccination in Italy? 234
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 233
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 232
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 231
Preventing and managing herpes zoster: key actions to foster healthy aging 226
Monitoring the web to support vaccine coverage: Results of two years of the portal VaccinarSì 226
Varicella vaccination in Europe – taking the practical approach 225
Detection and genotyping of human papillomavirus in urine samples from unvaccinated male and female adolescents in Italy. 225
The epidemiology of mumps in Italy 220
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 219
The epidemiology of Varicella Zoster Virus infection in Italy. 217
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 215
New Italian immunisation plan is built on scientific evidence: Carlo Signorelli and colleagues reply to news article by Michael Day 213
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 200
Erratum: Corrigendum to “Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines” (Vaccine (2016) 34(6) (757–761) (S0264410X15018745) (10.1016/j.vaccine.2015.12.063)) 196
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 195
Lifelong vaccination as a key disease-prevention strategy 191
Incidence of infection-associated cancers in Italy and prevention strategies 187
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 184
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 179
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 175
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 174
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 163
Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy 162
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 160
Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy 159
Fake news and covid-19 in Italy: Results of a quantitative observational study 154
The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting 146
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 145
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 144
Economic burden of HPV9-related diseases: a real-world cost analysis from Italy 143
[The 2014 lifetime immunization schedule approved by the Italian scientific societies. Italian Society of Hygiene, Preventive Medicine, and Public Health. Italian Society of Pediatrics. Italian Federation of Pediatric Physicians. Italian Federation of General Medical Physicians. Arezzo Service of Legal Medicine] 142
The "Fluad Case" in Italy: Could it have been dealt differently? 141
The burden of hospitalization due to HPV infections in Tuscany, Central Italy 138
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 135
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 134
Progress in Italy in control and elimination of measles and congenital rubella. 131
A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use 127
Assessing vaccine hesitancy among healthcare workers: A cross-sectional study at an Italian paediatric hospital and the development of a healthcare worker’s vaccination compliance index 127
Recommended vaccinations for asplenic and hyposplenic adult patients 125
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 124
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 123
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 123
Manuale di igiene e sanità pubblica 122
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 119
SORVEGLIANZA DEGLI EVENTI AVVERSI AI VACCINI SEGNALATI IN TOSCANA NEL 2015 117
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 115
Progress in Italy in control and elimination of measles and congenital rubella. 114
Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population. 112
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 111
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 111
Prevention of viral hepatitis in Italy 110
Health literacy and vaccination: A systematic review 110
An economic evaluation of varicella vaccination in Italian adolescents. 109
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 109
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 108
Prevalence of Hepatitis A virus infection in sewage plant workers of Central Italy: is indication for vaccination justified? 108
Success stories in the implementation of universal hepatitis B vaccination: an update on Italy. 107
Factors influencing vaccine uptake in Italy 107
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 106
Is hepatitis B vaccination performed at infant and adolescent age able to provide long-term immunological memory? An observational study on healthcare students and workers in Florence, Italy 106
Vaccination against hepatitis A during outbreaks starting in schools: what can we learn from experiences in central Italy? 106
Focusing on the implementation of 21st century vaccines for adults 104
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 104
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 103
Implementation in Italy of a universal vaccination programme against hepatitis B 102
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence 102
Economic evaluation of Varicella vaccination: results of a systematic review. 102
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 102
An overview on the implementation of HPV vaccination in Europe. 102
An economic evaluation of universal pertussis vaccination in Italy 101
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 101
Vaccination against hepatitis B in Health Care workers 101
Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy 101
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. 100
Measurement and reporting of burden of disease for hepatitis a: results of the EUROHEP.NET feasibility survey 99
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 99
Demographic impact of vaccination: a review 99
Lessons from an online vaccine communication project 98
Cervical cancer prevention: An Italian scenario between organised screening and Human papillomaviruses vaccination 98
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 98
Experience of hepatitis A vaccination during an outbreak in a nursery school of Tuscany, Italy. 97
The expected impact of new vaccines and vaccination policies. 96
Awareness of hepatitis B and C screening and patient management guidelines among health professionals in six European countries 96
Adiuvanti e vaccini coniugati 96
Totale 15.893
Categoria #
all - tutte 94.753
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.753


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.280 0 0 0 0 504 490 426 552 413 381 432 82
2020/20213.098 255 303 158 346 145 361 148 269 264 487 138 224
2021/20222.224 81 261 140 86 54 69 66 214 73 101 355 724
2022/20235.953 583 942 294 367 390 1.090 784 337 705 49 197 215
2023/20242.730 123 261 443 195 167 293 158 367 109 237 213 164
2024/20259.522 615 1.820 1.145 2.426 3.516 0 0 0 0 0 0 0
Totale 33.514